Spotlight on new approach to tuberculosis vaccine funding

European politicians, tuberculosis (TB) advocates and health advisers are gathering to discuss an innovative financing model that would enable scientific discoveries to be translated into TB vaccines.  On the occasion of aWorld TB Day meeting, Joris Vandeputte...

Progress in tuberculosis vaccine research

Collaboration and funding are some of the major requirements for delivering new, more effective and safer vaccines against tuberculosis (TB). This was a much-heard statement during the annual research meeting of the TuBerculosis Vaccine Initiative ...

Clinical trial capacity remains challenge for TB vaccine research

Tallinn, Estonia: While progress is being made in the development of new vaccines against tuberculosis (TB), sufficient clinical trial capacity remains a major challenge, researchers reaffirmed at the Second Global Forum on TB Vaccines  in Tallinn, Estonia (21-24...

TB doesn't get the prioritization it needs

Tallinn, Estonia: Tuberculosis (TB) is considered a major public health issue by decision makers, yet commonly doesn't get the place of importance it needs as a health care priority. These are the preliminary results of a study presented at the Second Global Forum on TB...

A new TB vaccine could be ready by 2020

The current tools are not enough to control tuberculosis epidemic. The 2009 World Health Organization (WHO) Global Tuberculosis Report says that the incidence of TB per capita continues to go down since 2004 however the decline is just one per cent per year which implies that...

Finland: H1N1 has spread to whole country

Whole Finland have fallen in H1N1 last week. About 2% of the population are infected and 10 persons have died this far. Situation is getting worse during next two weeks, but health care is already running out from resources. About 10% of the population have recevied the...